Ensitrelvir Shows Promise Preventing COVID-19 Post Exposure

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Daily oral drug reduced COVID-19 risk by 67% in exposed but uninfected adults
Medscape Medical News